10x Genomicsの将来のP / E
10x Genomicsの将来のP / Eは何ですか。
10x Genomics, Inc.の将来のP / Eは196.08です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
NASDAQのセクタHealth Careにおける将来のP / Eの企業と比べる10x Genomics
10x Genomicsは何をしますか。
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomicsと類似の将来のp / e
- Bajaj Finservの将来のP / Eは182.01です。
- Alibaba Health Information Technologyの将来のP / Eは185.19です。
- MakeMyTrip Ltdの将来のP / Eは187.87です。
- Alibaba Health Information Technologyの将来のP / Eは188.68です。
- Medexus Pharmaceuticals Incの将来のP / Eは188.68です。
- Wynn Macauの将来のP / Eは188.68です。
- 10x Genomicsの将来のP / Eは196.08です。
- Brooks Automationの将来のP / Eは197.84です。
- Dropsuiteの将来のP / Eは200.00です。
- Medexus Pharmaceuticalsの将来のP / Eは200.00です。
- Doximityの将来のP / Eは200.00です。
- CRH Medicalの将来のP / Eは200.00です。
- Horizon Discovery plcの将来のP / Eは200.00です。